Internal Medicine, Cardiovascular Disease · Las Vegas, NV
NPI
1205842580
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3150 N Tenaya Way, Suite 320
Las Vegas, NV, 89128
Phone (702) 240-6482
Groups this clinician bills Medicare through
Medicare paid, 2024
$709K
9,805 services
Medicare patients, 2024
2,187
Average age 75
Drug cost, 2024
$1.2M
5,054 prescriptions
Company payments, 2025
$1,025
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nicholas Tselikis was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 1,800 times for 18 patients. In total Nicholas Tselikis billed 9,805 services in 67 codes, and Medicare paid $709K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-05-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 1,800 | 18 | $0.10 | $188 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,679 | 166 | $36.09 | $61K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,164 | 172 | $45.83 | $53K |
| 99214 Office E&M - Established | Office | 883 | 500 | $86.87 | $77K |
| 99213 Office E&M - Established | Office | 704 | 438 | $63.56 | $45K |
| 93000 Electrocardiogram | Office | 645 | 520 | $9.87 | $6,369 |
| 93229 Electrocardiogram | Office | 550 | 542 | $627.20 | $345K |
| 93228 Electrocardiogram | Office | 550 | 542 | $19.02 | $10K |
| 93010 Electrocardiogram | Facility | 528 | 442 | $6.19 | $3,269 |
| 93306 Echocardiography (TTE/TEE) | Office | 298 | 292 | $136.75 | $41K |
| 93306 Echocardiography (TTE/TEE) | Facility | 124 | 122 | $52.29 | $6,483 |
| 99232 Hospital E&M - Subsequent | Facility | 111 | 88 | $59.35 | $6,588 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 95 | 58 | $54.03 | $5,133 |
| 99457 E&M - Miscellaneous | Office | 80 | 32 | $38.14 | $3,052 |
| 99454 E&M - Miscellaneous | Office | 79 | 33 | $36.99 | $2,922 |
By year: 2022 $921K for 12,583 services; 2023 $754K for 9,300 services; 2024 $709K for 9,805 services.
Medicare prescription drug claims, 2024
In 2024, the drug Nicholas Tselikis prescribed most often to Medicare patients was Amlodipine Besylate, with 472 prescriptions and refills. In total Nicholas Tselikis wrote 5,054 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 472 | 1,391 | 176 | $2,814 |
| Metoprolol Tartrate Generic | 368 | 1,073 | 122 | $2,714 |
| Atorvastatin Calcium Generic | 341 | 969 | 107 | $2,756 |
| Rosuvastatin Calcium Generic | 313 | 852 | 96 | $3,385 |
| Eliquis Apixaban | 285 | 564 | 76 | $320K |
| Losartan Potassium Generic | 281 | 804 | 106 | $2,846 |
| Metoprolol Succinate Generic | 275 | 799 | 103 | $3,060 |
| Xarelto Rivaroxaban | 244 | 602 | 81 | $327K |
| Carvedilol Generic | 188 | 552 | 63 | $1,778 |
| Lisinopril Generic | 166 | 446 | 53 | $1,087 |
| Entresto Sacubitril/Valsartan | 152 | 343 | 42 | $222K |
| Ezetimibe Generic | 144 | 428 | 46 | $4,289 |
| Clopidogrel Clopidogrel Bisulfate | 140 | 404 | 50 | $1,566 |
| Valsartan Generic | 134 | 372 | 44 | $3,575 |
| Hydralazine Hcl Generic | 86 | 252 | 32 | $1,137 |
Brand drugs: 1,051 claims; generic drugs: 4,003 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nicholas Tselikis $1,025 ($1,025 in general payments such as food, travel and fees) from 11 companies. The largest payer was Cardiva Medical, Inc. with $333.
| Company | Payments | Amount |
|---|---|---|
| Cardiva Medical, Inc. | 25 | $333 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $203 |
| BridgeBio Pharma, Inc. BBIO | 5 | $122 |
| Abbott Laboratories ABT | 2 | $121 |
| Cleerly, Inc. | 1 | $65.46 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $49.21 |
| Merck Sharp & Dohme LLC MRK | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34.43 |
| Alnylam Pharmaceuticals Inc. ALNY | 1 | $19.87 |
| Boston Scientific Corporation BSX | 1 | $19.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.